Sarepta Therapeutics, Inc.
US ˙ NasdaqGS ˙ US8036071004

SecuritySRPT / Sarepta Therapeutics, Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership2,102 shares
Latest Disclosed Value $ 45,235
Parallel Advisors, LLC ownership in SRPT / Sarepta Therapeutics, Inc.

On February 11, 2026 - Parallel Advisors, LLC filed a 13F-HR form disclosing ownership of 2,102 shares of Sarepta Therapeutics, Inc. (US:SRPT) valued at $45,235 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 2,016 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 4.27% during the quarter. The current value of the position is $34,136 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 2,102 86 4.27 45 18.42 0.0008
2025-11-13 2025-09-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 2,016 1,256 165.26 39 216.67 0.0007
2025-07-08 2025-06-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 760 -233 -23.46 13 -80.95 0.0003
2025-04-08 2025-03-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 993 170 20.66 64 -37.00 0.0014
2025-02-10 2024-12-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 823 -3 -0.36 100 -2.91 0.0023
2024-11-13 2024-09-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 826 140 20.41 103 -4.63 0.0024
2024-08-08 2024-06-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 686 61 9.76 108 35.00 0.0028
2024-05-06 2024-03-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 625 17 2.80 81 37.93 0.0022
2024-02-12 2023-12-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 608 -15 -2.41 59 -22.67 0.0017
2024-05-20 2023-09-30 13F/A-1 SAREPTA THERAPEUTICSINC COM Stock 803607100 623 -21 -3.26 76 2.74 0.0025
2023-11-14 2023-09-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 623 -21 76 0.0025
2024-05-20 2023-06-30 13F/A-1 SAREPTA THERAPEUTICSINC COM Stock 803607100 644 478 287.95 74 231.82 0.0024
2023-08-04 2023-06-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 644 478 74 0.0024
2024-05-20 2023-03-31 13F/A-1 SAREPTA THERAPEUTICSINC COM Stock 803607100 166 5 3.11 23 10.00 0.0008
2023-04-25 2023-03-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 166 5 23 0.0008
2023-02-06 2022-12-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 161 -280 -63.49 21 -59.18 0.0009
2022-11-10 2022-09-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 441 84 23.53 49 81.48 0.0023
2022-08-01 2022-06-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 357 -18 -4.80 27 -6.90 0.0012
2022-04-28 2022-03-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 375 -106 -22.04 29 -32.56 0.0012
2022-01-20 2021-12-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 481 100 26.25 43 22.86 0.0016
2021-11-02 2021-09-30 13F/A-1 SAREPTA THERAPEUTICSINC COM Stock 803607100 381 162 73.97 35 105.88 0.0014
2021-08-06 2021-06-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 219 39 21.67 17 30.77 0.0007
2021-04-23 2021-03-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 180 108 150.00 13 8.33 0.0006
2021-02-02 2020-12-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 72 -8 -10.00 12 9.09 0.0007
2020-10-27 2020-09-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 80 0 0.00 11 -8.33 0.0007
2020-07-16 2020-06-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 80 -2 -2.44 12 50.00 0.0008
2020-04-27 2020-03-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 82 30 57.69 8 14.29 0.0006
2020-01-30 2019-12-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 52 14 36.84 7 133.33 0.0005
2019-11-01 2019-09-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 38 -43 -53.09 3 -75.00 0.0003
2019-08-05 2019-06-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 81 -8 -8.99 12 9.09 0.0012
2019-05-01 2019-03-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 89 38 74.51 11 120.00 0.0012
2019-02-05 2018-12-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 51 12 30.77 5 -16.67 0.0007
2018-11-01 2018-09-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 39 10 34.48 6 100.00 0.0007
2018-07-30 2018-06-30 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 29 0 0.00 3 50.00 0.0004
2018-05-08 2018-03-31 13F SAREPTA THERAPEUTICSINC COM Stock 803607100 29 0 0.00 2 0.00 0.0003
2018-02-13 2017-12-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 29 0 0.00 2 0.00 0.0003
2017-11-15 2017-09-30 13F/A-1 SAREPTA THERAPEUTICS INC COM Stock 803607100 29 -300 -91.19 2 -84.62 0.0003
2017-08-07 2017-06-30 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 329 300 1,034.48 13 1,200.00 0.0025
2017-05-12 2017-03-31 13F/A-1 SAREPTA THERAPEUTICS INC COM Stock 803607100 29 29 1 0.0002
2017-05-12 2017-03-31 13F SAREPTA THERAPEUTICS INC COM Stock 803607100 29 1
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F SAREPTA THERAPEUTICSINC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F SAREPTA THERAPEUTICSINC COM Stock Call 219 17 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.